First batch of coronavirus vaccine Sputnik V enters civil circulation in Moscow
Russian state-affiliated media has reported that the first batch of coronavirus vaccine Sputnik-V has come into civil circulation. Sputnik V, an adenovirus vector-based vaccine, is developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and was registered on August 11.
While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest.
Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon.
More than 60,000 people had applied to volunteer for the coronavirus vaccine trials in Moscow and over 700 people were injected with the coronavirus vaccine.
Notably, Russian President Vladamir Putin has offered to provide the vaccine to United Nations staff for free.
“Russia is ready to offer UN workers the necessary, qualified help, and in particular we propose to supply our vaccine for free to employees of the organisation and its subsidiaries who volunteer for vaccination,” said Putin during his speech at this year’s UN General Assembly meeting.
